ZyVersa Therapeutics’ CEO, Stephen C. Glover to Present at the Stifel 2020 Virtual Healthcare Conference on November 18, 2020
- Monday, November 16, 2020, 7:10
- Environment
- Add a comment
WESTON, Fla., Nov. 16, 2020 /PRNewswire/ — ZyVersa Therapeutics, Inc. (ZyVersa), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, is pleased to announce that Stephen C. Glover, ZyVersa’s Co-Founder,…
About the Author
adminasapcorp has written 41616 stories on this site.